|
Volumn 3, Issue 3, 1997, Pages 305-322
|
Redox control as a target for anticancer drug development
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
1 AZIRIDINO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL;
5 (1 AZIRIDINYL) 3 HYDROXYMETHYL 2 (3 HYDROXY 1 PROPENYL) 1 METHYL 4,7 INDOLEDIONE;
AMINE OXIDE;
ANTINEOPLASTIC AGENT;
ANTIOXIDANT;
BRYOSTATIN;
CELL PROTEIN;
ETACRYNIC ACID;
GLUTATHIONE;
GLUTATHIONE REDUCTASE;
HETEROCYCLIC COMPOUND;
HETEROCYCLIC NITRO COMPOUND;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
METALLOPROTEIN;
METRONIDAZOLE;
MISONIDAZOLE;
MITOFLAXONE;
MITOMYCIN C;
NICOTINAMIDE;
NITROIMIDAZOLE DERIVATIVE;
OLTIPRAZ;
ORGANOSULFUR DERIVATIVE;
PORFIROMYCIN;
QUINONE DERIVATIVE;
THIOREDOXIN;
THIOREDOXIN REDUCTASE;
TIRAPAZAMINE;
TRANSCRIPTION FACTOR;
APOPTOSIS;
CANCER;
CELL CYCLE;
CELL METABOLISM;
CELL PROLIFERATION;
DNA SYNTHESIS;
DRUG DESIGN;
DRUG DEVELOPMENT;
HUMAN;
HYPOXIA;
OXIDATION REDUCTION REACTION;
OXIDATION REDUCTION STATE;
OXIDATIVE STRESS;
PRIORITY JOURNAL;
REVIEW;
|
EID: 0030762375
PISSN: 13816128
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (3)
|
References (16)
|